UNI MEDICAL (02666) has announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd., has received approval from the China Securities Regulatory Commission to issue domestic public corporate bonds with a total principal amount of up to RMB 8 billion to qualified investors in the People's Republic of China. As of the date of this announcement, the remaining quota for these bonds is RMB 3.4 billion. The bonds will be issued in multiple tranches. The second tranche of bonds for 2026 will have a total issuance principal not exceeding RMB 1 billion (including RMB 1 billion), with a base term of five years. The bonds include issuer redemption options at the end of the third and fourth years, an option to adjust the coupon rate, and an investor put option.
Comments